Bill Nygren
Oakmark Select Fund
Oakmark Select Fund Portfolio 13F
Bill Nygren Holdings Activity
- Portfolio value:
- $8.31B~ (+$745M~)
- Previous value:
- $7.57B~
- # of changes:
- 21
- New positions:
- 1
- Reported for:
- 30 Jun 2026 (Q2)
- Latest filing date:
- 26 Aug 2026
Oakmark Select Fund has disclosed a total of 21 changes to the portfolio in the latest (2026 Q2) SEC report(s): increased the number of shares of 13, bought 1 totally new, decreased the number of shares of 5 and completely sold out 2 position(s).
What stocks is Bill Nygren buying now?
In the recent quarter Bill Nygren has bought 14 securities out of which top 5 purchases (by % change to portfolio) are (KDP) Keurig Dr Pepper Inc (added shares +0.98%), (CRM) Salesforce.com Inc (added shares +15.45%), (IQV) IQVIA Holdings Inc (added shares +11.04%), (MRSH) Marsh & McLennan Companies, Inc (added shares +84.86%) and (SCHW) Charles Schwab Corp (added shares +42.97%).
21 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Alphabet Inc, CL-C
|
new
|
+289,908
|
289,908
|
+1.23%
|
$353.33
|
-6.03%($332.02)
|
1.23%
|
2026 Q2
|
~0.25 years
|
|
|
|
Marsh & McLennan Companies, Inc
|
+84.86%
|
+1,295,100
|
2,821,300
|
+2.6%
|
$166.67
|
+12.65%($187.76)
|
5.66%
|
2026 Q1
|
~0.50 years
|
|
|
|
Charles Schwab Corp
|
+42.97%
|
+1,387,700
|
4,616,940
|
+1.54%
|
$92.27
|
+17.49%($108.40)
|
5.13%
|
2023 Q1
|
~3.50 years
|
|
|
|
Capital One Financial Corp
|
+21.95%
|
+315,000
|
1,750,097
|
+0.76%
|
$200.62
|
+5.65%($211.95)
|
4.22%
|
2019 Q3
|
~7.00 years
|
|
|
|
Intercontinental Exchange Inc
|
+19.63%
|
+493,000
|
3,004,853
|
+0.73%
|
$123.11
|
+29.53%($159.47)
|
4.45%
|
2022 Q4
|
~3.75 years
|
|
|
|
Salesforce.com Inc
|
+15.45%
|
+456,900
|
3,413,900
|
+0.86%
|
$156.66
|
+64.49%($257.69)
|
6.43%
|
2025 Q2
|
~1.25 years
|
|
|
|
Gartner Inc
|
+13.24%
|
+163,000
|
1,394,000
|
+0.25%
|
$129.62
|
+48.46%($192.44)
|
2.17%
|
2026 Q1
|
~0.50 years
|
|
|
|
IQVIA Holdings Inc
|
+11.04%
|
+259,100
|
2,605,500
|
+0.6%
|
$193.22
|
+34.34%($259.58)
|
6.06%
|
2023 Q3
|
~3.00 years
|
|
|
|
Equifax Inc
|
+7.86%
|
+103,000
|
1,414,000
|
+0.2%
|
$158.72
|
+18.01%($187.31)
|
2.70%
|
2024 Q4
|
~1.75 years
|
|
|
|
Charles River Laboratories
|
+7.15%
|
+100,000
|
1,498,000
|
+0.27%
|
$226.79
|
+24.80%($283.04)
|
4.09%
|
2025 Q2
|
~1.25 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".